圣诺生物：预计2025年上半年净利润同比增加253.54%-332.10%

Core Viewpoint - The company expects significant growth in net profit for the first half of 2025, with projections indicating an increase of over 250% compared to the same period last year [1] Financial Projections - The company anticipates a net profit attributable to shareholders ranging from 77.03 million to 94.14 million yuan for the first half of 2025, representing an increase of 55.24 million to 72.36 million yuan year-on-year, which corresponds to a growth rate of 253.54% to 332.10% [1] - The expected net profit after deducting non-recurring gains and losses is projected to be between 77.35 million and 94.53 million yuan, with an increase of 58.22 million to 75.41 million yuan compared to the previous year, reflecting a growth rate of 304.49% to 394.38% [1]